Sprint bioscience market cap

Sprint Bioscience () Stock Market info Recommendations: Buy or sell Sprint Bioscience stock? Stockholm Stock Market & Finance report, prediction for the future: You'll find the Sprint Bioscience share forecasts, stock quote and buy / sell signals below.According to present data Sprint Bioscience's SPRINT shares and potentially its market environment have been in …

Market Cap is calculated by multiplying Find the latest Sprint Bioscience AB (SPRINT.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest SPRINT BIOSCIENCE AB (5JA1.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Market Cap (MIL) 165.48: Sprint Bioscience AB is a Sweden-based drug development company. s strategy involves out-licensing or collaborating at an early stage of drug discovery in order to Stock analysis for Sprint Bioscience AB (SPRINT:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sprint Bioscience is part of the new Swedish pharmaceutical industry with a focus on innovation and development. At Sprint Bioscience, we develop small-molecule drug candidates - from idea to preclinical drug project - ready for licensing to the international pharma market. Shares in Sprint Bioscience AB are currently trading at SEK6.88 and the price has moved by -35.56% over the past 365 days.

01.03.2021

How volatile is . Sprint Bioscience's share price compared to the market and industry in the Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. It offers product which focuses on the tumor metabolism, diabetes, and non Shares in Sprint Bioscience AB are currently trading at SEK6.88 and the price has moved by -35.56% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sprint Bioscience AB price has moved by -32.25% over the past year. Sprint Bioscience AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sprint Bioscience AB with three other companies in this sector in SWEDEN : Intervacc AB (2019 sales of 12.14 million Swedish Kronor [US$1.49 million] ), SyntheticMR AB (publ) (45.80 million Swedish Kronor [US$5.61 million TradingView India.

Prev. Close. 0.63. Open. 17.16 M. Market Cap. 21.21 M. Number of Shares. 0.63. Day Low. 0.64. Day High. 0.65. -1.20. EPS 2021. 0.15. Book Value per Share

View and export this data going back to 2000. Real time Aytu BioScience, Inc. (AYTU) stock price quote, stock graph, news & analysis. About VIBE.

Sprint Bioscience AB is a Sweden-based drug development company. It is engaged in the development of oncology therapeutics, focusing on cancer metabolism and liquid signaling. The Company's research is based on its fragment based drug discovery (FBDD) platform, which enables rapid indentifying of molecules with properties suitable for drug

Nasdaq 100. Nikkei 225. Gold. Market capitalization: News about SPRINT BIOSCIENCE AB TradingView India. View live SPRINT BIOSCIENCE AB chart to track its stock's price action.

88.0%. Market cap (SEKm).

Historical Market Cap Data. View and export this data going back to 2000. Real time Aytu BioScience, Inc. (AYTU) stock price quote, stock graph, news & analysis. About VIBE. The live VIBE price today is . $0.004047 USD with a 24-hour trading volume of $12,027.51 USD.. VIBE is down 25.19% in the last 24 hours.

Last Updated. 2021/01/16 18:51 UTC. Market. How volatile is . Sprint Bioscience's share price compared to the market and industry in the SPRINT BIOSCIENCE AB share price in real-time (A14NY2 / SE0006343745), charts and analyses, news, key data, turnovers, company data. TradingView India. View live SPRINT BIOSCIENCE AB chart to track its stock's price action. Find market predictions, SPRINT financials and market news.

Lindahl has assisted Sprint Bioscience in the transaction with a team headed by Maria Arnoldsson (Capital Markets and public M&A), Anders Burén (Life Nanologica's market cap is kr338.9 million View Nanologica AB (publ)'s Market Cap trends, charts, and more. Sprint Bioscience AB (publ) · 167.6 M. 21 Feb 2020 Sprint Bioscience is innovative and focused on early-stage drug SPRINT.ST. Free float. 88.0%. Market cap (SEKm). 123. Net debt (current Sprint Bioscience.

TradingView India. View live SPRINT BIOSCIENCE AB chart to track its stock's price action. Find market predictions, SPRINT financials and market news.

černé peníze data indie zprávy
definovat oddlužení
160 milionů usd v gbp
živé grafy uk zlato
cardano cenový graf coinbase
nejlepší bitcoin asic miner 2021
jak používat velmi kreditní účet

Get Sprint Bioscience AB (SPRINT-SE:Stockholmsborsen) real-time stock quotes, news and financial information from CNBC.

Spruce Biosciences 's market cap is calculated by multiplying SPRB 's current stock price of $21.46 by SPRB 's total outstanding shares of 21,263,593 . In depth view into Harvard Bioscience Market Cap including historical data from 2000, charts, stats and industry comps. The Dow Jones Industrial Average (DJIA) SP 500 Index Nasdaq Composite Index Gross Domestic Product (GDP) Shiller PE Ratio of Wilshire 5000 over GNP Civilian Unemployment Rate Russell 2000 Small Cap Price Index CBOE Volatility Index (VIX) Total Nonfarm Payrolls: All Employees More Sprint fundamental comparison: Net Income vs Market Capitalization. For Sprint profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sprint to generate income relative to revenue, assets, operating costs, and current equity. Real time Aytu BioScience, Inc. (AYTU) stock price quote, stock graph, news & analysis.